HIGHLIGHTS
- who: Tzu-Ning Tseng and colleagues from the Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial have published the Article: Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse, in the Journal: Viruses 2022, 1189 of /2022/
- what: This study investigated the kinetics in and the loss rate after entecavir or tenofovir disoproxil fumarate (TDF) cessation in patients with chronic hepatitis B (CHB) who achieved virological suppression after virological relapse without clinical relapse.
- future: Studies are needed to validate the practicality of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.